Janssen Pharmaceutica NV:企業のM&A・事業提携・投資動向

◆英語タイトル:Janssen Pharmaceutica NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2030
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:206
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Janssen Pharmaceutica NV – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Janssen Pharmaceutica NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Janssen Pharmaceutica NV since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Janssen Pharmaceutica NV’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Janssen Pharmaceutica NV. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Janssen Pharmaceutica NV’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Janssen Pharmaceutica NV and its subsidiaries since 2007.
- Information about key financial and legal advisors for Janssen Pharmaceutica NV’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Janssen Pharmaceutica NV’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
CORPORATE VENTURING 7
Corporate Venturing – Deal reports 7
PARTNERSHIP 13
Partnership – Overview 13
Partnership – Deal reports 14
DIVESTMENTS 178
Divestments – Overview 178
Divestments – Deal reports 179
APPENDIX 196
Contact Us 196
About MarketLine Financial Deals Database 196
Deal Definition and Methodology 198
About MarketLine 205

List of Tables
Table 1: Janssen Pharmaceutica NV partnership volume and value trend (2014-YTD2018)
Table 2: Janssen Pharmaceutica NV partnership trend by key deal type (2014-YTD2018)
Table 3: Janssen Pharmaceutica NV divestments volume and value trend (2014-YTD2018)

List of Figures
Figure 1: Janssen Pharmaceutica NV partnership volume and value trend (2014-YTD2018)
Figure 2: Janssen Pharmaceutica NV partnership trend by key deal type (2014-YTD2018)
Figure 3: Janssen Pharmaceutica NV divestments volume and value trend (2014-YTD2018)

★海外企業調査レポート[Janssen Pharmaceutica NV:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BioMarin Pharmaceutical Inc.:企業の戦略・SWOT・財務情報
    BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Harbour Centre Development Ltd:戦略・SWOT・企業財務分析
    Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Banque Cantonale Vaudoise (Private Banking):企業の戦略・SWOT・財務情報
    Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • E*Trade Financial Corp:企業の戦略・SWOT・財務情報
    E*Trade Financial Corp - Strategy, SWOT and Corporate Finance Report Summary E*Trade Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dauntless Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dauntless Pharmaceuticals Inc (Dauntless Pharma) is a drug development company that develops therapeutic agents. The company’s pipeline products include DP1038 and DP2018. Its DP1038 is an intranasal octreotide formulation used as a therapeutic agent for the treatment of acromegaly and neuro …
  • AGR Holdings AS:企業の戦略的SWOT分析
    AGR Holdings AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • General Motors Company:企業の戦略・SWOT・財務情報
    General Motors Company - Strategy, SWOT and Corporate Finance Report Summary General Motors Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • CeraPedics Inc:医療機器:M&Aディール及び事業提携情報
    Summary CeraPedics Inc (Cerapedics) is a medical device company that develops and commercializes novel osteobiologic products. The company’s products include i-factor putty, a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to i …
  • Hyundai Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務分析
    Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Diamond Offshore Drilling Inc (DO):石油・ガス:M&Aディール及び事業提携情報
    Summary Diamond Offshore Drilling Inc (Diamond Offshore) is an offshore oil and gas drilling company, which provides contract drilling services to the energy industry. It operates through a fleet of offshore drilling rigs comprising semisubmersibles, jack-ups, and dynamically positioned drillships. …
  • Bukwang Pharm Co Ltd (003000):製薬・医療:M&Aディール及び事業提携情報
    Summary Bukwang Pharm Co Ltd (Bukwang Pharmaceutical) is a pharmaceutical company that develops new drugs and pharmaceutical products. The company’s products portfolio includes dexid, thioctacid, levovir, legalon, Orfil, azeptin, lonasen, ixel, and asima, among others. Its pipeline products comprise …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • America Movil, SA DE C.V.:戦略・SWOT・企業財務分析
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Human Longevity Inc-製薬・医療分野:企業M&A・提携分析
    Summary Human Longevity Inc (HLI) is a genomics-based, technology-driven company which develops database of whole genome, phenotype and clinical data. Its discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomark …
  • Bioasis Technologies Inc (BTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • Galecto Biotech AB-製薬・医療分野:企業M&A・提携分析
    Summary Galecto Biotech AB (Galecto Biotech) is a biotech company that focuses on the development of novel drugs for the treatment of fibrosis, inflammation, and other diseases. The company’s products act against galectins or galactoside binding lectins, a group of proteins that are involved in vari …
  • Chugoku Marine Paints Ltd (4617):企業の財務・戦略的SWOT分析
    Chugoku Marine Paints Ltd (4617) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Ames Construction Inc:企業の戦略的SWOT分析
    Ames Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • GTT Communications Inc (GTT):企業の財務・戦略的SWOT分析
    GTT Communications Inc (GTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆